NT-proBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells' response to cardiac surgery

Atherosclerosis. 2008 Jul;199(1):138-46. doi: 10.1016/j.atherosclerosis.2007.09.045. Epub 2007 Nov 8.

Abstract

Objective: We used cardiac surgery as a model of acute inflammatory response to evaluate the role of the inflammatory mediators in influencing the number of circulating endothelial progenitor cells (EPCs).

Methods: In 38 coronary artery by-pass grafting (CABG) [28M/10F] and in 54 valvular [28M/26F] patients the numbers of EPCs and the serum levels of IL-1ra, IL-6, IL-8, IL-10, vascular endothelial growth factor (VEGF), high sensitivity C-reactive protein (hsCRP) and NT-proBNP were determined before (T1), 72h (T2), and 10 days after cardiac intervention (T3). Peripheral blood EPCs were measured by flow cytometric analysis and were defined as CD34+KDR+, CD133+KDR+ and CD34+CD133+KDR+.

Results: We demonstrate that the cardiac surgery reduces, 72h after intervention, the number of all the three types of EPCs with a contemporary marked increase of pro-inflammatory and anti-inflammatory cytokines and NT-proBNP levels. At baseline, EPC number was inversely related with age. At multiple linear regression analysis, after adjusting for age, cardiovascular risk factors and medications, age and IL-8 serum levels were significantly related to EPC number. At T2, an inverse relationship between NT-proBNP and the number of EPCs was found in the whole study population. At T3, 10 days after the intervention, at multivariate linear regression analysis, IL-10 and IL-1ra serum levels were significantly and positively associated with EPC number.

Conclusions: This study provides new insights into the relationship between inflammatory activation and mobilisation of EPCs in patients underwent cardiac surgery, by showing that NT-ProBNP and cytochemokines mediate the EPC changes in acute and post-acute response to the inflammatory stimulus of intervention.

MeSH terms

  • Acute-Phase Reaction / immunology
  • Aged
  • Aged, 80 and over
  • C-Reactive Protein / immunology
  • C-Reactive Protein / metabolism
  • Coronary Artery Bypass*
  • Cytokines / blood
  • Cytokines / immunology*
  • Endothelial Cells / cytology
  • Endothelial Cells / immunology*
  • Female
  • Flow Cytometry
  • Humans
  • Inflammation / immunology*
  • Inflammation / metabolism
  • Interleukin 1 Receptor Antagonist Protein / blood
  • Interleukin 1 Receptor Antagonist Protein / immunology
  • Interleukin-10 / blood
  • Interleukin-10 / immunology
  • Interleukin-6 / blood
  • Interleukin-6 / immunology
  • Interleukin-8 / blood
  • Interleukin-8 / immunology
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain / blood
  • Natriuretic Peptide, Brain / immunology*
  • Peptide Fragments / blood
  • Peptide Fragments / immunology*
  • Stem Cells / cytology
  • Stem Cells / immunology*
  • Vascular Endothelial Growth Factor A / blood
  • Vascular Endothelial Growth Factor A / immunology

Substances

  • Cytokines
  • IL10 protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-6
  • Interleukin-8
  • Peptide Fragments
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
  • Interleukin-10
  • C-Reactive Protein